During the past 12 months, Eton Pharmaceuticals's average Revenue per Share Growth Rate was 22.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 20.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 178.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Eton Pharmaceuticals was 751.30% per year. The lowest was 20.30% per year. And the median was 150.10% per year.
Competitive Comparison of Eton Pharmaceuticals's 3-Year Revenue Growth Rate
For the Drug Manufacturers - Specialty & Generic subindustry, Eton Pharmaceuticals's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eton Pharmaceuticals's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eton Pharmaceuticals's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Eton Pharmaceuticals's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Eton Pharmaceuticals 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of Eton Pharmaceuticals's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ETON has been successfully added to your